Table 3.
Symptoms on VAS in the patient group and the control group
| Symptoms | Mean Preoperatively VAS (SD ) | Mean Postoperatively VAS (SD ) | P-value1 | Control group | P-value2 |
|---|---|---|---|---|---|
| Nasal blockage | 71(SD20) | 29(SD26) | 0.000 | 9 (11) | 0.000 |
| Headache | 33(SD30) | 18(SD25) | 0.000 | 16 (20) | 0.5 |
| Facial pain | 16(SD24) | 7(SD14) | 0.000 | 9 (17) | 0.4 |
| Altered sense of smell | 31(SD32) | 12(SD24) | 0.000 | 5 (9) | 0.009 |
| Nasal discharge | 42(SD32) | 22(SD29) | 0.000 | 11 (19) | 0.003 |
| Sneezing | 32(SD28) | 17(SD23) | 0.000 | 14 (15) | 0.3 |
| Trouble with rhinosinusitis | 16(SD28) | 4(SD12) | 0.000 | 3 ( 7) | 0.9 |
| Cough | 22(SD27) | 9(SD17) | 0.000 | 7 ( 9) | 0.3 |
| Snoring | 54(SD33) | 26(SD26) | 0.000 | 26 (29) | 0.8 |
| Oral breathing | 63(SD30) | 23(SD27) | 0.000 | 13 (22) | 0.01 |
| Reduced general health | 47(SD31) | 12(SD20) | 0.000 | 5 ( 6) | 0.007 |
P-value1 is the p-value for improvement from preoperatively to postoperatively. P-value 2 is the p-value for a difference in postoperative symptoms in the patients compared to the controls